A team of medical researchers and engineers at RSP Systems, in Denmark, working with a pair of colleagues from the Institute ...
AI-powered, internet-connected medical devices have the potential to revolutionize health care by enabling early disease ...
Combination treatment with a GLP-1 agonist and thiazolidinedione in type 2 diabetes was tied to a significantly lower risk of ...
First Update in Nearly 10 Years by FITTER Forward Initiative Sets Out to Transform Insulin Injection Technique EducationPARSIPPANY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") ...
Full REMAIN-1 pivotal study enrollment anticipated in summer 2025 ...
A new Norwegian study finds that one hour of screen time at bedtime results in a 59% higher risk of insomnia and 24 fewer ...
An alleged prototype of the Apple Watch Series 10 has a brand new sensor that may have been intended for blood sugar ...
Novo Nordisk already has broad FDA approvals in hand for its injected semaglutide products Ozempic and Wegovy to reduce the ...
UK evangelist Carl Beech has publicly announced he is stepping down from his role as President of Christian Vision for Men (CVM) and Edge Ministries to focus on other projects and his health battles ...
An advanced hybrid closed-loop insulin delivery system is safe to use for pregnant women with type 1 diabetes and may provide ...
On March 27, 2025, Vivani announced an $8.25 million equity financing which secures solid financial position into the second quarter of 2026 and enables acceleration of priority development programs, ...
Vertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback